Montelukast sodium (MS) in addition to sodium cromoglycate (SCG) on the airway response to the same cumulative dose of inhaled mannitol Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005
Comparison of salbutamul, nedocromil sodium and disodium cromoglycate (DSCG) protective effects in patients with exercise induced bronchoconstriction (EIB) Source: Eur Respir J 2002; 20: Suppl. 38, 306s Year: 2002
Sodium cromoglycate inhibits release of mast cell mediators and bronchoconstriction following hyperpnea in athletes Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing Source: Eur Respir J 2006; 27: 944-950 Year: 2006
Prevention of exercise-induced bronchoconstriction (EIB) by a fixed combination of disodium cromoglycate plus reproterol compared to montelukast Source: Eur Respir J 2004; 24: Suppl. 48, 443s Year: 2004
Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review Source: Eur Respir J 2001; 17: 39-45 Year: 2001
Inhalation of mannitol, used as a model for exercise-induced bronchoconstriction (EIB), causes release of leukotrienes and a mast cell marker in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
Pharmacological agents used to treat asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=339 Year: 2003
Low doses of inhaled fluticasone propionate induce sputum eosinophil apoptosis and inhibit IL-5 release in naive symptomatic asthmatics (FLIC19) Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Salbutamol but not ipratropium fully abolish leukotriene D4 -induced gas exchange abnormalities and induced sputum eosinophilia in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003
Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Source: Eur Respir J 2004; 23: 559-564 Year: 2004
Effect of long-term treatment with inhaled furosemide and nedocromil sodium on exercise-induced broncho-obstruction in asthmatic children Source: Eur Respir J 2001; 18: Suppl. 33, 495s Year: 2001
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD Source: Eur Respir J 2003 Dec 01;22(6):926-930 Year: 2003
Montelukast inhibits bronchoconstriction and gas exchange defects induced by leukotriene D4 challenge in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002
Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Leukotriene involvement in metabisulphite (MBS) induced bronchoconstriction Source: Eur Respir J 2002; 20: Suppl. 38, 411s Year: 2002
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002
Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF -induced murine model of asthma Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009